logo

Cytori Therapeutics Inc. (CYTX)



Trade CYTX now with
  Date
  Headline
6/12/2018 8:33:16 AM Cytori Informs Stockholders Of Key Dates And Terms Related To Announced Rights Offering
5/10/2018 4:25:46 PM Cytori Q1 Net Loss $4.4 Mln Or $0.07 Per Share
4/30/2018 8:33:24 AM Cytori Updates On US Manufacturing And EU Approval Plans For ATI-0918, Liposomal Doxorubicin
3/8/2018 4:28:20 PM Cytori Therapeutics Q4 Net Loss $4.3 Mln Or $0.10 Per Share
1/22/2018 9:03:10 AM Cytori : Enrollment Completed In Randomized Trial Of Habeo Cell Therapy For Scleroderma And Impaired Hand Function
11/24/2017 9:01:18 AM Cytori Says Rights Offering Oversubscribed By More Than 75%
11/20/2017 9:04:01 AM Cytori Reports Reduction In Fibrosis Parameters In Scar Study
11/16/2017 8:02:50 AM Cytori Announces Bioequivalence Trial Results In Ovarian Cancer At AAPS
8/10/2017 4:26:15 PM Cytori Therapeutics Q2 Loss/share $0.19 Vs. Loss $0.43 Year Ago
7/25/2017 4:32:57 PM Cytori Therapeutics Reports Inducement Grants For New Employees
7/24/2017 8:01:45 AM Cytori Announces Top-Line Results From STAR Trial Of Habeo Cell Therapy In Patients With Scleroderma